Invesco’s Zhengye Biotechnology Holding ZYBT Stock Holding History

Invesco’s Portfolio ZYBT Stock Details ZYBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,688	Closed	-$39.9K	–	3841
2025 Q4	$39.9K	Sell	34,688 -1,763	-5%	-$3.91K	﹤0.01%	3723
2025 Q3	$95.5K	Sell	36,451 -388	-1%	-$2.69K	﹤0.01%	3691
2025 Q2	$220K	Buy	+36,839	New	+$292K	﹤0.01%	3488

Other funds holding ZYBT

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Invesco's ZYBT Position: Q1 2026 in Review

Invesco sold out of Zhengye Biotechnology Holding (ZYBT) in Q1 2026, closing a stake of 34,688 shares — an estimated $39.9K sold.

Invesco first reported a position in ZYBT in Q2 2025 and held it in 3 quarters. The position peaked at $220K in Q2 2025. 8 funds tracked by Wall St. Rank hold ZYBT as of Q1 2026.

Invesco reported no remaining Zhengye Biotechnology Holding position as of Q1 2026 after selling out during the quarter.
Invesco sold 34,688 Zhengye Biotechnology Holding shares in Q1 2026, an estimated $39.9K.
Invesco first reported a position in Zhengye Biotechnology Holding in Q2 2025 and held it in 3 quarters.
Invesco's Zhengye Biotechnology Holding position peaked at $220K in Q2 2025.
8 funds tracked by Wall St. Rank held Zhengye Biotechnology Holding as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.